Your Health Plan:
Your Health Plan:
Not SelectedRYSTIGGO (rozanolixizumab) is a biologic prescription drug for treatment of Myasthenia Gravis, Generalized. RYSTIGGO is a neonatal fc receptor blocker. It is available in the form of subcutaneous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $7200-8700.
Patient Assistance Prorgams are found: